XTX Topco’s AstraZeneca AZN Stock Holding History

XTX Topco’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$743K	Buy	3,766 +903	+32%	+$174K	0.01%	1677
2025 Q4	$526K	Sell	2,863 -5,777	-67%	-$1.01M	0.01%	1547
2025 Q3	$1.33M	Buy	+8,640	New	+$1.31M	0.07%	408
2025 Q2	–	Sell	-11,111	Closed	-$1.63M	–	2356
2025 Q1	$1.63M	Sell	11,111 -18,440	-62%	-$2.67M	0.08%	325
2024 Q4	$3.87M	Buy	29,551 +13,286	+82%	+$1.86M	0.32%	26
2024 Q3	$2.53M	Buy	16,265 +9,375	+136%	+$1.51M	0.18%	87
2024 Q2	$1.07M	Buy	+6,890	New	+$1.04M	0.09%	336
2024 Q1	–	Sell	-7,576	Closed	-$1.02M	–	1841
2023 Q4	$1.02M	Buy	+7,576	New	+$985K	0.22%	30
2023 Q3	–	Sell	-4,890	Closed	-$700K	–	1560
2023 Q2	$700K	Buy	+4,890	New	+$719K	0.13%	208
2023 Q1	–	Sell	-11,675	Closed	-$1.58M	–	1267
2022 Q4	$1.58M	Buy	+11,675	New	+$1.46M	0.34%	20
2022 Q2	–	Sell	-3,149	Closed	-$418K	–	845
2022 Q1	$418K	Sell	3,149 -2,436	-44%	-$292K	0.18%	184
2021 Q4	$651K	Buy	+5,585	New	+$657K	0.37%	44
2021 Q3	–	Sell	-8,370	Closed	-$1M	–	687
2021 Q2	$1M	Buy	+8,370	New	+$918K	0.34%	42

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

XTX Topco's AZN Position: Q1 2026 in Review

XTX Topco increased its AstraZeneca (AZN) stake by 32% in Q1 2026, buying an estimated $174K and bringing the position to 3,766 shares worth $743K. The position accounts for 0.01% of the portfolio, ranked #1677.

XTX Topco first reported a position in AZN in Q2 2021 and has held it in 13 quarters since. The position peaked at $3.87M in Q4 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

XTX Topco held 3,766 shares of AstraZeneca worth $743K as of Q1 2026.
XTX Topco bought 903 AstraZeneca shares in Q1 2026, an estimated $174K.
AstraZeneca made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1677 holding.
XTX Topco first reported a position in AstraZeneca in Q2 2021 and has held it in 13 quarters since.
XTX Topco's AstraZeneca position peaked at $3.87M in Q4 2024.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.